Remed Co Ltd
KOSDAQ:302550
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Remed Co Ltd
Total Liabilities & Equity
Remed Co Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
R
|
Remed Co Ltd
KOSDAQ:302550
|
Total Liabilities & Equity
₩59.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Total Liabilities & Equity
₩577.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Total Liabilities & Equity
₩704.6B
|
CAGR 3-Years
29%
|
CAGR 5-Years
39%
|
CAGR 10-Years
50%
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Total Liabilities & Equity
₩177.9B
|
CAGR 3-Years
150%
|
CAGR 5-Years
73%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Total Liabilities & Equity
₩98.1B
|
CAGR 3-Years
49%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Total Liabilities & Equity
₩28.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Remed Co Ltd
Glance View
REMED Co., Ltd. is engaged in the manufacturing of other medical equipment. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2018-08-14. The firm is involved in the manufacturing and sale of transcranial magnetic stimulation (TMS) therapy machines, pain therapy machines, electrosurgical units as well as biosignal and monitoring machines. The pain therapy machines include electromagnetic stimulation machines, extracorporeal shockwave therapy machines and high intensity laser therapy machines, among others. The biosignal and monitoring machines include patient monitors, fetal monitors, electrocardiogram (ECG/EKG) machines, among others. The firm distributes its products within the domestic market and to overseas markets.
See Also
What is Remed Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
59.1B
KRW
Based on the financial report for Dec 31, 2024, Remed Co Ltd's Total Liabilities & Equity amounts to 59.1B KRW.
What is Remed Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
11%
Over the last year, the Total Liabilities & Equity growth was 7%. The average annual Total Liabilities & Equity growth rates for Remed Co Ltd have been -9% over the past three years , 11% over the past five years .
